“Real-Life” Data of Zanubrutinib in Patients with Waldenström Macroglobulinemia: A Multicenter Retrospective Study
The results of this real-world high-risk population are consistent with prospective studies highlighting the efficacy and safety of ZAN.
Authors
- Moshe E. Gatt (ORCID: https://orcid.org/0000-0002-9426-4482)
- Mor Levi
- Anatoly Nemets
- Mahdi Assaly
- Anna Gourevitch
- Gilad Itchaki (ORCID: https://orcid.org/0000-0002-9064-8139)
- Ohad Benjamini (ORCID: https://orcid.org/0000-0003-1123-3339)
- Iuliana Vaxman (ORCID: https://orcid.org/0000-0002-8390-064X)
- Revital Saban
- Pia Raanani (ORCID: https://orcid.org/0000-0001-9973-639X)
- Shai Ygna
Institutions
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Sheba Medical Center (IL)
- Hadassah Medical Center (IL)
- Rabin Medical Center (IL)
- Soroka Medical Center (IL)
- Hillel Yaffe Medical Center (IL)
- Meir Medical Center (IL)
- Barzilai Medical Center (IL)
- Poriya Medical Center (IL)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1159/000542936
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00